The stock of Tandem Diabetes Care Inc (NASDAQ:TNDM) is a huge mover today! The stock decreased 3.92% or $0.1 on November 30, hitting $2.45. About 247,258 shares traded hands. Tandem Diabetes Care Inc (NASDAQ:TNDM) has declined 75.46% since April 27, 2016 and is downtrending. It has underperformed by 80.68% the S&P500.
The move comes after 6 months negative chart setup for the $72.24M company. It was reported on Nov, 30 by Barchart.com. We have $2.28 PT which if reached, will make NASDAQ:TNDM worth $5.06 million less.
Analysts await Tandem Diabetes Care Inc (NASDAQ:TNDM) to report earnings on February, 22. They expect $-0.62 earnings per share, down 55.00% or $0.22 from last year’s $-0.4 per share. After $-0.97 actual earnings per share reported by Tandem Diabetes Care Inc for the previous quarter, Wall Street now forecasts -36.08% EPS growth.
Tandem Diabetes Care Inc (NASDAQ:TNDM) Ratings Coverage
Out of 9 analysts covering Tandem Diabetes Care (NASDAQ:TNDM), 3 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 33% are positive. Tandem Diabetes Care has been the topic of 17 analyst reports since August 5, 2015 according to StockzIntelligence Inc. Zacks downgraded the shares of TNDM in a report on Friday, August 28 to “Buy” rating. The stock of Tandem Diabetes Care Inc (NASDAQ:TNDM) earned “Outperform” rating by Wedbush on Wednesday, November 2. The firm has “Hold” rating by Zacks given on Friday, September 4. The stock of Tandem Diabetes Care Inc (NASDAQ:TNDM) has “Buy” rating given on Wednesday, November 2 by Deutsche Bank. The stock of Tandem Diabetes Care Inc (NASDAQ:TNDM) earned “Buy” rating by Deutsche Bank on Monday, August 10. The stock of Tandem Diabetes Care Inc (NASDAQ:TNDM) earned “Sell” rating by Zacks on Wednesday, August 5. The firm has “Buy” rating by Zacks given on Thursday, August 20. Stifel Nicolaus downgraded the shares of TNDM in a report on Wednesday, November 2 to “Hold” rating. Robert W. Baird downgraded the stock to “Neutral” rating in Wednesday, November 2 report. Zacks upgraded the shares of TNDM in a report on Saturday, August 22 to “Hold” rating.
According to Zacks Investment Research, “Tandem Diabetes Care, Inc. is a medical device company. The Company designs, develops, and commercializes products for people with insulin-dependent diabetes. Its products include t:slim Insulin Delivery System. Tandem Diabetes Care, Inc. is headquartered in San Diego, California.”
Insitutional Activity: The institutional sentiment increased to 1.32 in Q2 2016. Its up 0.30, from 1.02 in 2016Q1. The ratio is positive, as 18 funds sold all Tandem Diabetes Care Inc shares owned while 24 reduced positions. 9 funds bought stakes while 34 increased positions. They now own 17.85 million shares or 6.33% less from 19.06 million shares in 2016Q1.
Moreover, Essex Investment Mngmt Ltd Liability Corporation has 0.07% invested in Tandem Diabetes Care Inc (NASDAQ:TNDM) for 58,796 shares. Senzar Asset Management Limited Liability has 615,311 shares for 0% of their US portfolio. State Street has 222,780 shares for 0% of their US portfolio. Motley Fool Asset Ltd Liability owns 390,000 shares or 0.64% of their US portfolio. Wells Fargo And Mn last reported 0% of its portfolio in the stock. Natl Bank Of Ny Mellon accumulated 214,673 shares or 0% of the stock. Numeric Investors Limited Liability holds 0% of its portfolio in Tandem Diabetes Care Inc (NASDAQ:TNDM) for 43,043 shares. First Mercantile Tru accumulated 17,822 shares or 0.02% of the stock. First Republic Invest Mgmt accumulated 0% or 58,838 shares. Rhumbline Advisers reported 16,317 shares or 0% of all its holdings. D E Shaw & Inc last reported 67,179 shares in the company. Northern Tru owns 222,010 shares or 0% of their US portfolio. Blackrock Advisors Ltd Liability Co accumulated 0% or 624,433 shares. Franklin Resources holds 0.01% or 1.26M shares in its portfolio. Moreover, Bnp Paribas Arbitrage Sa has 0% invested in Tandem Diabetes Care Inc (NASDAQ:TNDM) for 720 shares.
More recent Tandem Diabetes Care Inc (NASDAQ:TNDM) news were published by: Businesswire.com which released: “Tandem Diabetes Care to Present at the 28th Annual Piper Jaffray Healthcare …” on November 10, 2016. Also Businesswire.com published the news titled: “Tandem Diabetes Care Reports Third Quarter 2016 Financial Results” on November 01, 2016. Businesswire.com‘s news article titled: “NIH-funded International Diabetes Closed Loop (IDCL) Trial to Combine …” with publication date: November 10, 2016 was also an interesting one.
TNDM Company Profile
Tandem Diabetes Care, Inc., incorporated on January 7, 2008, is a medical device company. The Firm is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Firm makes and sells over three insulin pump products in the United States that are designed to address insulin-dependent diabetes market, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). The Company’s technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism. The Firm also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud data management application that provides display therapy management data from the pump and supported blood glucose meters.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.